Rezum water vapour therapy: promising early outcomes from the first UK series
暂无分享,去创建一个
T. Nedas | R. Hindley | M. Noureldin | A. Emara | L. Paramore | M. Johnston | G. Rajkumar | Y. Abdelmotagly | T. Gehring
[1] C. Roehrborn,et al. Rezūm Water Vapor Thermal Therapy for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: 4-Year Results From Randomized Controlled Study. , 2019, Urology.
[2] K. Tsui,et al. Transurethral resection of the prostate provides more favorable clinical outcomes compared with conservative medical treatment in patients with urinary retention caused by benign prostatic obstruction , 2018, BMC Geriatrics.
[3] C. Roehrborn,et al. Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. , 2017, The Canadian journal of urology.
[4] C. Roehrborn,et al. Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. , 2016, The Journal of urology.
[5] F. Montorsi,et al. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study. , 2015, European urology.
[6] F. Bruyère,et al. A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study. , 2015, The Journal of urology.
[7] L. Mynderse,et al. Transurethral convective water vapor as a treatment for lower urinary tract symptomatology due to benign prostatic hyperplasia using the Rezūm® system: evaluation of acute ablative capabilities in the human prostate , 2015, Research and reports in urology.